Ignite Creation Date:
2024-10-26 @ 3:39 PM
Last Modification Date:
2024-10-26 @ 3:39 PM
Study NCT ID:
NCT06577896
Status:
RECRUITING
Last Update Posted:
None
First Post:
2024-08-27
Brief Title:
The Study to Evaluate the Safety and Efficacy of the Onyx Family
Sponsor:
None
Organization:
None
Study Overview
Official Title:
Safety and Efficacy of 1-month Dual Antiplatelet Therapy in High Bleeding and Ischemic Risk Elderly Patients With Coronary Artery Disease After Implantation of Zotarolimus-eluting Coronary Stent System Onyx Family Medtronic Minneapolis MN A Multicenter Prospective Observational Study
Status:
RECRUITING
Status Verified Date:
2024-09
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
No
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
Observation of the safety and efficacy of 1-month dual antiplatelet therapy DAPT after percutaneous coronary intervention using Onyx family stents in elderly patients aged 75 years or older
Detailed Description:
For elderly patients aged 75 years or older undergoing percutaneous coronary intervention with Onyx family drug-eluting stents observe the safety and efficacy of transitioning from dual antiplatelet therapy to single therapy for one year after one month of dual antiplatelet therapy
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None